What happened
AriBioLab updated the terms of a private placement (third-party allotment) to raise US$13.1M, about 16.5% of its market value.
For context, this raise equals about 16.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$13.1M |
| vs. market value | 16.5% |
| Filed | 2026-09-16, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260916000511 → open original filing |
Versions of this filing
- 2026-09-16Original
- 2026-09-16Amendment 1 (this page)
Source: DART. Information only, not investment advice.